Sick from a nasty stomach bug? Moderna's Norovirus vaccine might be the solution
Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...
Sick of the stomach bug? Moderna is making a norovirus vaccine
Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
pulmonologyadvisor6d
Moderna Provides Update on Norovirus Vaccine Candidate
Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.
Volunteers aim to give a knockout jab to norovirus
Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...
Becker's Hospital Review6d
Moderna races to create norovirus vaccines
Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.
Cases of norovirus are on the rise. Here’s how you can protect yourself from the stomach bug
Lehigh Valley’s health networks are seeing abnormally high cases of the stomach bug that’s taking a large number of people ...
Moderna's stock is falling. Goldman Sachs says it's no longer a buy.
Shares of vaccine maker Moderna Inc. fell Wednesday as Goldman Sachs lowered its rating after the biotech's second cut to product revenue guidance in six months. Moderna shares (MRNA) fell 2% in ...